[Study on Norplant carried out by the Gabes regional committee].
D000349:Africa; D000352:Africa, Northern; D001519:Behavior; D003267:Contraception; D003268:Contraception Behavior; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003906:Developing Countries; D005193:Family Planning Services; D006285:Health Planning; D016912:Levonorgestrel; D008877:Middle East; D010342:Patient Acceptance of Health Care; D010549:Personal Satisfaction; D015995:Prevalence; D011584:Psychology; D012106:Research; D012107:Research Design; D014416:Tunisia
D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D016912:Levonorgestrel
Acceptor Characteristics; Acceptors; Africa; Arab Countries; Behavior; Contraception; Contraception Continuation; Contraceptive Agents, Female--side effects; Contraceptive Agents, Progestin--side effects; Contraceptive Agents--side effects; Contraceptive Effectiveness; Contraceptive Implants; Contraceptive Methods; Contraceptive Usage; Developing Countries; Family Planning; Family Planning Programs; French Speaking Africa; Levonorgestrel--side effects; Measurement; Mediterranean Countries; Method Acceptability; Northern Africa; Prevalence; Psychological Factors; Research Methodology; Research Report; Reversibility; Satisfaction; Tunisia